12/28
01:08 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
Medium
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
12/20
01:30 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
11/22
02:11 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
11/18
08:00 am
acxp
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
Low
Report
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
11/15
07:05 pm
acxp
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television [Yahoo! Finance]
Medium
Report
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television [Yahoo! Finance]
11/12
07:21 am
acxp
Acurx Pharmaceuticals GAAP EPS of -$1.23 beats by $0.05 [Seeking Alpha]
High
Report
Acurx Pharmaceuticals GAAP EPS of -$1.23 beats by $0.05 [Seeking Alpha]
11/12
07:01 am
acxp
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
High
Report
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
11/10
08:43 am
acxp
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens [Yahoo! Finance]
High
Report
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens [Yahoo! Finance]
11/10
08:00 am
acxp
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
Medium
Report
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
10/28
08:00 am
acxp
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
Medium
Report
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
10/27
08:00 am
acxp
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
Medium
Report
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update